ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-pxxvii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-pxxvii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-pxiv.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-pxiv.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p4.xml JNCCN at 102026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p4.pdf2026-04-18 JNCCN at 10https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p1.xmlCorrespondence2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p1.pdf2026-04-18Correspondencehttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p3.xml JNCCN Reaches 102026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p3.pdf2026-04-18 JNCCN Reaches 10https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p26.xmlMalignant Pleural Mesothelioma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p26.pdf2026-04-18Malignant Pleural Mesotheliomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p18.xmlValue-Based Insurance Design: Aligning Incentives, Benefits, and Evidence in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p18.pdf2026-04-18Value-Based Insurance Design: Aligning Incentives, Benefits, and Evidence in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p7.xmlBy the Pricking of My Thumbs, Something Wicked This Way Comes*: Sporadic Cancers Versus Eponymous Hereditary Cancer Predisposition Syndromes2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p7.pdf2026-04-18By the Pricking of My Thumbs, Something Wicked This Way Comes*: Sporadic Cancers Versus Eponymous Hereditary Cancer Predisposition Syndromeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p64.xmlChronic Myelogenous Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p64.pdf2026-04-18Chronic Myelogenous Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p112.xmlHow to Choose Frontline Therapy for Chronic Myelogenous Leukemia: So Many Drugs, Not So Many Patients2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p112.pdf2026-04-18How to Choose Frontline Therapy for Chronic Myelogenous Leukemia: So Many Drugs, Not So Many Patientshttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p49.xmlCurrent Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p49.pdf2026-04-18Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesotheliomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p42.xmlNovel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p42.pdf2026-04-18Novel Therapies in Phase II and III Trials for Malignant Pleural Mesotheliomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p130.xmlHealth Care Reform and Its Implications for the Academic Cancer Center2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p130.pdf2026-04-18Health Care Reform and Its Implications for the Academic Cancer Centerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p121.xmlPractical Monitoring of Chronic Myelogenous Leukemia: When to Change Treatment2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/10/1/article-p121.pdf2026-04-18Practical Monitoring of Chronic Myelogenous Leukemia: When to Change Treatment